Overview

  • Product nameAnti-CCNL1 antibody
    See all CCNL1 primary antibodies
  • Description
    Rabbit polyclonal to CCNL1
  • SpecificityThis antibody is specific for human Cyclin L1a and shows negligible reactivity to Cyclin L1 beta or Cyclin L2 isoforms.
  • Tested applicationsSuitable for: ELISA, WB, IHC-P, IP, ICC/IFmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Chicken, Dog, Chimpanzee
  • Immunogen

    Synthetic peptide: KLKAKGL NP DGTPALST L GGFSPASKP SSPREVKAEE KSPISINVK Q, corresponding to amino acids 314-369 of Human CCNL1

  • Positive control
    • For Western blotting : Mouse brain whole cell lysate. For IHC: A variety of tissues including breast, heart, kidney [distal tubules], liver, skeletal muscle, spleen.

Properties

Applications

Our Abpromise guarantee covers the use of ab34709 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA
WB
IHC-P
IP
ICC/IF
  • Application notesELISA: 1/5000 - 1/25,000.
    ICC/IF: Use at an assay dependent dilution.
    IHC-P: Use at a concentration of 10 - 20 µg/ml.
    IP: Use at an assay dependent dilution.
    WB: 1/2000 - 1/5000. Predicted molecular weight: 59 kDa. Approximately 35µg of lysate was separated by 4-20% SDS-PAGE followed by transfer to nitrocellulose. After blocking the membrane was probed with the primary antibody diluted to 1:3,500 for 2h at room temperature followed by washes and reaction with a 1:10,000 dilution of IRDye™800 conjugated Gt-a-Rabbit IgG [H&L] for 45 min at room temperature.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionTranscriptional regulator which participates in regulating the pre-mRNA splicing process. Seems to be involved in the regulation of RNA polymerase II (pol II). Functions in association with cyclin-dependent kinases (CDKs) and has a role in the second step of splicing. May be a candidate proto-oncogene in head and neck squamous cell carcinomas (HNSCC). Inhibited by the CDK-specific inhibitor p21.
    • Tissue specificityUbiquitous with higher level in thymus. Overexpression in primary tumors of head and neck squamous cell carcinomas (HNSCC).
    • Sequence similaritiesBelongs to the cyclin family. Cyclin L subfamily.
    • DomainContains a RS region (arginine-serine dipeptide repeat) within the C-terminal domain which is the hallmark of the SR family of splicing factors. This region probably plays a role in protein-protein interactions.
    • Cellular localizationNucleus speckle. More specifically found in nuclear intrachromatin granules clusters (IGC), also called nuclear speckles, which are storage compartments for nuclear proteins involved in mRNA processing.
    • Information by UniProt
    • Database links
    • Alternative names
      • Ania 6a antibody
      • CCNL1 antibody
      • CCNL1_HUMAN antibody
      • Cyclin L antibody
      • Cyclin L gamma antibody
      • Cyclin L1 antibody
      • Cyclin-L antibody
      • Cyclin-L1 antibody
      see all

    Anti-CCNL1 antibody images

    • This image shows human spleen stained with ab34709 at 10µg/ml

    References for Anti-CCNL1 antibody (ab34709)

    ab34709 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab34709.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"